SCHEMBL2200838

SCHEMBL2200838

CC(C)(C)N(C(=O)O)C(C)(C)CCN1CCN(c2ccc(F)cc2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.50
DRD3 P35462 6/20 0.50
RAB9A P51151 1/20 0.48
HDAC1 Q13547 5/20 0.44
KCNH2 Q12809 2/20 0.43
DPP4 P27487 1/20 0.41
PKM P14618 1/20 0.41
S1PR1 P21453 1/20 0.41
PER2 O15055 2/20 0.41
CRY2 Q49AN0 1/20 0.39
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907493 0.79 DRD2 (0.52) DRD2DRD3RAB9AHDAC1KCNH2
Trifluoroacetic Acid SCHEMBL2199631 0.78 DRD2 (0.51) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL2198557 0.78 DRD2 (0.59) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL12427164 0.73 DRD2 (0.48) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL27716316 0.72 DRD2 (0.62) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL12510232 0.71 DRD2 (0.46) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL6221920 0.70 RAB9A (0.69) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL18937416 0.70 RAB9A (0.69) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL4919307 0.68 DRD2 (0.46) DRD2DRD3RAB9AHDAC1KCNH2
SCHEMBL8151399 0.67 DRD2 (0.62) DRD2DRD3RAB9AHDAC1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977334-B2 N-(3-{2-[3-(6-amino-benzimidazol-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide; beta(3)-Adrenoceptor agonists; antidiabetic, obesity modulator, insulin resistance BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-12 US disclosed